Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

3 Aug 2013

Abstract excerpt

BACKGROUND: Post treatment minimal residual disease (MRD) determination contributes to impending relapse prediction, chemotherapy response and clinical outcomes assessment, guiding clinicians to develop reasonable and effective individual chemotherapy options after induction/consolidation. This study was to identify serum candidate peptides for monitoring adult acute myeloid leukemia (AML) MRD. RESULTS: 47...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Advanced Proteomics Techniques and Applications
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23915341
DOI: 10.1186/1477-5956-11-39

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profilingPMID 23915341Read ↗

Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspectiveSemantic proximity Read ↗

Machine Learning Driven Dashboard for Chronic Myeloid Leukemia Prediction using Protein SequencesSemantic proximity Read ↗

A List of Candidate Cancer Biomarkers for Targeted ProteomicsSemantic proximity Read ↗

Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics.Semantic proximity Read ↗

Graft-versus-host disease biomarkers: omics and personalized medicine.Semantic proximity Read ↗

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repairSemantic proximity Read ↗

[Predictive Value of Acute Phase Proteins on the Prognosis of Patients with Acute Myeloid Leukemia].Semantic proximity Read ↗

Potentiality of Protein phosphatase Mg2+ /Mn2+ dependent 1D as a biomarker for predicting prognosis in acute myeloid leukemia patients.Semantic proximity Read ↗

Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia.Semantic proximity Read ↗

Proteomic approaches in myeloid leukemia.Semantic proximity Read ↗

High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB subtypes M4 and M5Semantic proximity Read ↗

A comparative proteomic study of plasma in Colombian childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.